The University of Southampton
University of Southampton Institutional Repository

Are we investing wisely? A systematic analysis of nationally funded antimicrobial resistance projects in Republic of Korea, 2003–2013

Are we investing wisely? A systematic analysis of nationally funded antimicrobial resistance projects in Republic of Korea, 2003–2013
Are we investing wisely? A systematic analysis of nationally funded antimicrobial resistance projects in Republic of Korea, 2003–2013
From 2003–2013, South Korea has conducted the National Antimicrobial Resistance Safety Control Program (NARSCP). The purpose of the current study was to systematically review national antimicrobial resistance (AMR) research trends and to provide guidance on future allocation of research funding to enable a comprehensive approach in AMR control. This study collected project reports related to AMR published by the Ministry of Food and Drug Safety, the Ministry of Health and Welfare and the Korea Centers for Disease Control and Prevention between 2003 and 2013. These reports were analysed by topics based on the AMR action plan of the World Health Organization (WHO), period of study, categories along the research pipeline and types of receiving institution. A total of 198 project reports were included, with total funding of US$18.3 million. Mean funding per award was US$92 750, with a median of US$71 714. Among the WHO-suggested criteria, the basic microbial research and surveillance sector accounts for 143 (72.2%) of all awards. Yearly project funding increased from US$961 476 in 2003 to US$1 553 294 in 2013. Operational research was 61.5% and product development was 0.7% of the basic microbial research and surveillance sector. By institution, academia received 145 awards (73.2%). During progress of the NARSCP, total research funding increased significantly, but most awards were focused on understanding the overall picture of the nationwide AMR status. More balanced funding is needed, and encouraging active participation of private and international sectors is also required in reducing AMR.
2213-7165
1-22
Ryu, Sukhyun
6a171057-64e7-449b-b1cd-818da71e4d25
Head, Michael
67ce0afc-2fc3-47f4-acf2-8794d27ce69c
Kim, Bryan I.
33d50a69-f163-412a-ac8a-6884479508d6
Cho, En-Hi
9bd471f1-f04a-4266-ae53-b8addf6e3c77
Ryu, Sukhyun
6a171057-64e7-449b-b1cd-818da71e4d25
Head, Michael
67ce0afc-2fc3-47f4-acf2-8794d27ce69c
Kim, Bryan I.
33d50a69-f163-412a-ac8a-6884479508d6
Cho, En-Hi
9bd471f1-f04a-4266-ae53-b8addf6e3c77

Ryu, Sukhyun, Head, Michael, Kim, Bryan I. and Cho, En-Hi (2016) Are we investing wisely? A systematic analysis of nationally funded antimicrobial resistance projects in Republic of Korea, 2003–2013. Journal of Global Antimicrobial Resistance, 1-22. (doi:10.1016/j.jgar.2016.03.007).

Record type: Article

Abstract

From 2003–2013, South Korea has conducted the National Antimicrobial Resistance Safety Control Program (NARSCP). The purpose of the current study was to systematically review national antimicrobial resistance (AMR) research trends and to provide guidance on future allocation of research funding to enable a comprehensive approach in AMR control. This study collected project reports related to AMR published by the Ministry of Food and Drug Safety, the Ministry of Health and Welfare and the Korea Centers for Disease Control and Prevention between 2003 and 2013. These reports were analysed by topics based on the AMR action plan of the World Health Organization (WHO), period of study, categories along the research pipeline and types of receiving institution. A total of 198 project reports were included, with total funding of US$18.3 million. Mean funding per award was US$92 750, with a median of US$71 714. Among the WHO-suggested criteria, the basic microbial research and surveillance sector accounts for 143 (72.2%) of all awards. Yearly project funding increased from US$961 476 in 2003 to US$1 553 294 in 2013. Operational research was 61.5% and product development was 0.7% of the basic microbial research and surveillance sector. By institution, academia received 145 awards (73.2%). During progress of the NARSCP, total research funding increased significantly, but most awards were focused on understanding the overall picture of the nationwide AMR status. More balanced funding is needed, and encouraging active participation of private and international sectors is also required in reducing AMR.

Text
JGAR Ryu et al AMR funding in Korea 2016.pdf - Accepted Manuscript
Download (259kB)

More information

Accepted/In Press date: 29 March 2016
e-pub ahead of print date: 7 May 2016
Organisations: Clinical & Experimental Sciences

Identifiers

Local EPrints ID: 393980
URI: https://eprints.soton.ac.uk/id/eprint/393980
ISSN: 2213-7165
PURE UUID: a6438f61-e6b2-435b-b903-5d2bbd81f465
ORCID for Michael Head: ORCID iD orcid.org/0000-0003-1189-0531

Catalogue record

Date deposited: 09 May 2016 13:53
Last modified: 19 Nov 2019 06:48

Export record

Altmetrics

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×